PI3K is believed to be one of the key therapeutic targets for cancer treatment, based on the observation that hyperactivity of PI3K signaling is significantly correlated with human tumoral progression, an increase in tumor micro vessel density and enhanced chemotaxis and invasive potential of cancer cells. Here, PIK3CB is linked to cancer.